EDGAR Filing Documents for 0001193125-11-109694

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-11-109694

Filing Date

2011-04-26

Accepted

2011-04-26 16:56:24

Documents

Period of Report

2011-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	d10q.htm	10-Q	521259
2	CO-DEVELOPMENT AND LICENSE AGREEMENT	dex105.htm	EX-10.5	485057
3	FORM OF 2007 EQUITY INCENTIVE PLAN RESTRICTED STOCK AWARD AGREEMENT FOR EMPLOYEE	dex106.htm	EX-10.6	27999
4	FORM OF 2007 EQUITY INCENTIVE PLAN RESTRICTED STOCK AWARD AGREEMENT FOR DIRECTOR	dex107.htm	EX-10.7	26630
5	CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302	dex311.htm	EX-31.1	7613
6	CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302	dex312.htm	EX-31.2	8031
7	CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 906	dex32.htm	EX-32	7500
8	GRAPHIC	g178110g82k07.jpg	GRAPHIC	4651
	Complete submission text file	0001193125-11-109694.txt		1091652

Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119

Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062827100

CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)